| |
Total (n = 59)
|
TDT (n = 33)
|
CMS (n = 26)
|
p value
|
|---|
|
Gender
|
0.939
|
|
Male
|
40
|
23
|
17
| |
|
Female
|
19
|
10
|
9
| |
|
Age (range)*
|
69 (46–90)
|
68 (46–90)
|
70 (50–85)
|
0.367
|
|
Diabetes mellitus
|
0.180
|
|
Positive
|
15
|
11
|
4
| |
|
Negative
|
44
|
22
|
22
| |
|
Body mass index, kg/m2 (range)*
|
–
|
20.9 (17.0–41.5)
|
20.7 (13.2–29.3)
|
0.803
|
|
Chief complaint
|
–
|
|
Abdominal pain/fullness
|
34
|
21
|
13
| |
|
Vomiting
|
4
|
3
|
1
| |
|
Constipation
|
5
|
3
|
2
| |
|
Bloody stool
|
7
|
3
|
4
| |
|
Diarrhea
|
1
|
1
|
0
| |
|
Anemia
|
4
|
0
|
4
| |
|
Others
|
4
|
2
|
2
| |
|
Tumor location
|
0.366
|
|
Transverse
|
2
|
0
|
2
| |
|
Descending
|
9
|
6
|
3
| |
|
Sigmoid
|
38
|
21
|
17
| |
|
Rectosigmoid
|
10
|
6
|
4
| |
|
Dilatation of the small bowel
|
|
Positive
|
27
|
16
|
11
|
0.749
|
|
Negative
|
32
|
17
|
15
| |
|
Maximum of dilatation of the colon, mm (range)*
|
–
|
59.9 (33.0–95.3)
|
48.8 (29.2–76.8)
|
0.099
|
|
CEA, ng/ml (range)*
| |
10.0 (2.9–490.8)
|
6.6 (1.0–1232.0)
|
0.242
|
|
TDT
|
33
|
–
|
–
| |
|
CMS
|
26
|
–
|
–
| |
|
Stage
|
0.441
|
|
II
|
22
|
11
|
11
| |
|
III
|
17
|
11
|
6
| |
|
IV
|
20
|
11
|
9
| |
- *median, TDT = trans-anal decompression tube, CMS = colonic metallic stent
